Articles Referencing ABAX

Zacks.com

Earnings Beat for ABAX, Sluggish Overall - Analyst Blog

Provider of portable blood analysis systems for human and veterinary patient-care, Abaxis Inc. ( ABAX ) reported fourth-quarter fiscal 2013 earnings per share ("EPS") of 30... Read >>

Zacks.com

Abaxis Pinned at Neutral - Analyst Blog

On Mar 28, we reiterated our long-term Neutral recommendation on Abaxis Inc. ( ABAX ) following healthy third quarter fiscal 2013 results. This manufacturer of portable blood analysis... Read >>

Zacks.com

QIAGEN Extends Portfolio - Analyst Blog

Global provider of molecular sample and assay technologies, QIAGEN N.V. ( QGEN ) remains committed to technological advancement and new product introductions as exhibited by its recent... Read >>

Zacks.com

St. Jude Prices Senior Notes - Analyst Blog

Medical devices giant St. Jude Medical, Inc. 's ( STJ ) recently announced that it will be offering 3.25% senior notes due 2023 for an aggregate purchase price of $900 million, and also... Read >>

Zacks.com

HOLX to Feature Innovative Products - Analyst Blog

Women's healthcare major Hologic Inc. ( HOLX ) will showcase the benefits of its leading-edge 3D mammography systems at the 23rd Annual National Interdisciplinary Breast Cancer Conference... Read >>

Zacks.com

Hologic Offloads LIFECODES Biz - Analyst Blog

Recently, Hologic Inc. ( HOLX ) completed the divestment of its LIFECODES business unit to Immucor Inc., a prominent player in the automated instrument-reagent systems space in the blood... Read >>

Zacks.com

Hanger Stays Neutral - Analyst Blog

On Mar 21, we retained Hanger Inc. ( HGR ) at Neutral, following its solid fourth-quarter 2012 results. In spite of the upbeat performance, we remain on the sidelines given the... Read >>

Zacks.com

Pediatric Exclusivity for Hospira's Drug - Analyst Blog

Hospira, Inc. ( HSP ) recently gained pediatric exclusivity from the US Food and Drug Administration (FDA) for its injectable sedation drug, Precedex (dexmedetomidine HCl). The FDA's... Read >>

Zacks.com

Stryker Launches Iconix - Analyst Blog

Orthopedic major, Stryker Corp. ( SYK ) has launched the Iconix all suture anchor platform with IntelliBraid technology at the American Academy of Orthopaedic Surgeons 2013 Annual... Read >>

Zacks.com

Plethora of Positive Data for GHDX - Analyst Blog

Genomic Health Inc. ( GHDX ) continues to demonstrate the clinical and economic merits of its Oncotype DX breast cancer test. The company recently featured positive data from 22 clinical... Read >>

Zacks.com

Excerpts from Medtronic's Confab - Analyst Blog

Recently, Medtronic ( MDT ) debriefed analysts about its ongoing performance in various divisions and markets during the Barclays Global Healthcare Conference. Below are the excerpts from... Read >>

Zacks.com

St. Jude's ILUMIEN OPTIS Now in Japan - Analyst Blog

Medical devices major, St. Jude Medical Inc. ( STJ ) has launched its latest ILUMIEN OPTIS System for the first time in Japan. This imaging technology is an advanced version of the... Read >>

Zacks.com

Epocal Acquired by Alere - Analyst Blog

Alere ( ALR ), a medical products company focused on integrating rapid diagnostics with health management, recently revealed that it has taken over Epocal, Inc., which is a seller of... Read >>

Benzinga

Market Wrap for Friday, February 1: Stocks Surge on Jobs Data

The Dow Jones Industrial Average closed Friday's trading session near 5 year highs as investors continue to pour money into equities to start the year. Relatively good economic data and... Read >>

Zacks.com

Abaxis Surpasses Estimates in 3Q - Analyst Blog

Provider of portable blood analysis systems for human and veterinary patient-care, Abaxis Inc. ( ABAX ) reported third quarter fiscal 2013 earnings per share (EPS) of 22 cents, a beat... Read >>

Displaying 1-15 of 19
<< first < previous 1 2 next > last >>